Riskpilot← Back to searchSign inGet full accessFRISK LEGEKONTOR AS
ASActiveOrg 998752396Bøkkerveien 4, 0579 OsloGeneral medical practice activities · NACE 8621Est. 20121 employees
Revenue 2024
NOK 7,1M
+44% vs 2023
EBITDA margin
67.2%
+64% vs 2023
Equity ratio
82.9%
Financial strength
Net profit 2024
NOK 1,3M
-21% vs 2023
| Revenue | NOK 7,1M | +44% |
| EBITDA | NOK 4,7M | +64% |
| Net profit | NOK 1,3M | -21% |
| Total assets | NOK 7,6M | +6% |
| Equity | NOK 6,3M | -8% |
| Employees | 1 | — |
Legal name
FRISK LEGEKONTOR AS
Org number
998752396
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
25. august 2012
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Å drive legevirksomhet og hva hermed står i forbindelse, samt deltakelse i andre selskaper og virksomheter.
Address
Bøkkerveien 4, 0579 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 747 | 5 206 | 5 896 | 4 916 | 7 062 |
| Staff expenses | −1 068 | −895 | −1 144 | −877 | −875 |
| EBITDA | 2 005 | 2 714 | 2 198 | 2 896 | 4 747 |
| Depreciation & amort. | −215 | −163 | −136 | −259 | −688 |
| EBIT | 1 789 | 2 552 | 2 061 | 2 638 | 4 059 |
| Net financials | 534 | −1 178 | −612 | −1 | −1 241 |
| Profit before tax | 2 323 | 1 374 | 1 449 | 2 637 | 2 819 |
| Tax | 387 | 576 | 453 | 1 023 | 1 544 |
| Net profit | 1 936 | 798 | 996 | 1 614 | 1 275 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 342 | 1 890 | 1 405 | 7 129 | 7 571 |
| Equity | 1 650 | 948 | 347 | 6 792 | 6 277 |
| Long-term debt | 7 | 5 | 5 | 0 | 131 |
| Short-term debt | 684 | 936 | 1 053 | 337 | 1 163 |
| Total debt | 692 | 941 | 1 058 | 337 | 1 295 |
EBITDA margin
67.2%
This company
15.8%
Market median
+325% vs market
20202024
Equity ratio
82.9%
This company
38.2%
Market median
+117% vs market
20202024
Return on equity
20.3%
This company
18.4%
Market median
+10% vs market
20202024
Net profit margin
18.0%
This company
8.1%
Market median
+122% vs market
20202024
Asset turnover
0.93×
This company
1.12×
Market median
+17% vs market
20202024
Debt / equity
0.21×
This company
0.62×
Market median
+66% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
SH Deputy Member | Deputy Member | 2012 |
FL Chief Executive Officer | Chief Executive Officer | 2012 |
| Former (1) | ||
BM Chief Executive Officer | Chief Executive Officer | 2012 – 2025 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of FRISK LEGEKONTOR AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Saira Hamid Basit | Deputy Member | 0 companies |
| Folke Louis Blix | Chief Executive Officer | 0 companies |
| Bahman Mehdinia | Chief Executive Officer | 0 companies |